| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |